Goldman Sachs Group Inc Trans Medics Group, Inc. Call Options Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
Call Options
1 transactions
Others Institutions Holding TMDX
# of Institutions
415Shares Held
29.9MCall Options Held
1.19MPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA3.6MShares$416 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$306 Million0.01% of portfolio
-
State Street Corp Boston, MA1.29MShares$149 Million0.01% of portfolio
-
Fil LTD Hamilton, D01.06MShares$122 Million0.13% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL956KShares$111 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $3.68B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...